STOPDAPT-3 Subanalysis on Prasugrel Monotherapy After Elective or Emergent Coronary Intervention in Patients with or Without Diabetes: Are We Ready for This?

Overview

Journal Eur Heart J Cardiovasc Pharmacother

Publisher Oxford University Press

Date 2024 Nov 19

PMID 39558848

Authors

Jeehoon Kang

Giuseppe Gargiulo

Affiliations

Soon will be listed here.

Citing Articles

Lipid treatment.

Agewall S Eur Heart J Cardiovasc Pharmacother. 2025; 11(2):105-106.

PMID: 40079901 PMC: 11905741. DOI: 10.1093/ehjcvp/pvaf009.

References

Galli M, Rollini F, Been L, Zenni M, Angiolillo D, Franchi F . Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease. J Thromb Thrombolysis. 2022; 54(3):461-469. DOI: 10.1007/s11239-022-02696-4. View

Gargiulo G, Valgimigli M, Capodanno D, Bittl J . State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation - past, present and future perspectives. EuroIntervention. 2017; 13(6):717-733. DOI: 10.4244/EIJ-D-17-00468. View

Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R . An aspirin-free strategy for percutaneous coronary intervention in patients with diabetes: a pre-specified subgroup analysis of the STOPDAPT-3 trial. Eur Heart J Cardiovasc Pharmacother. 2024; 11(1):34-44. PMC: 11805690. DOI: 10.1093/ehjcvp/pvae075. View

Gargiulo G, Windecker S, Vranckx P, Gibson C, Mehran R, Valgimigli M . A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?. Circulation. 2016; 134(23):1881-1906. DOI: 10.1161/CIRCULATIONAHA.116.023952. View

Gargiulo G, Windecker S, da Costa B, Feres F, Hong M, Gilard M . Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials. BMJ. 2016; 355:i5483. PMC: 5094199. DOI: 10.1136/bmj.i5483. View

Nogic J, Nerlekar N, Soon K, Freeman M, Chan J, Roberts L . Diabetes mellitus is independently associated with early stent thrombosis in patients undergoing drug eluting stent implantation: Analysis from the Victorian cardiac outcomes registry. Catheter Cardiovasc Interv. 2021; 99(3):554-562. DOI: 10.1002/ccd.29913. View

Marx N, Federici M, Schutt K, Muller-Wieland D, Ajjan R, Antunes M . 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023; 44(39):4043-4140. DOI: 10.1093/eurheartj/ehad192. View

Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R . An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial. Circulation. 2023; 149(8):585-600. DOI: 10.1161/CIRCULATIONAHA.123.066720. View

Giustino G, Colombo A, Camaj A, Yasumura K, Mehran R, Stone G . Coronary In-Stent Restenosis: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022; 80(4):348-372. DOI: 10.1016/j.jacc.2022.05.017. View

10.

Vrints C, Andreotti F, Koskinas K, Rossello X, Adamo M, Ainslie J . 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024; 45(36):3415-3537. DOI: 10.1093/eurheartj/ehae177. View

11.

Capodanno D, Angiolillo D . Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus. Circulation. 2020; 142(22):2172-2188. DOI: 10.1161/CIRCULATIONAHA.120.045465. View

12.

Dehghani P, Cao D, Baber U, Nicolas J, Sartori S, Pivato C . Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD. Eur Heart J Cardiovasc Pharmacother. 2022; 8(7):707-716. DOI: 10.1093/ehjcvp/pvac016. View